Astranordic Glow Pen · 140 mg / pen- ·Pre-filled 140 mg pen
- ·Alcohol swabs
Glow Blend 140 mg pen
Pre-filled dermal-blend pen — 140 mg presentation.
High-dose pre-filled pen version of the Glow dermal blend. 2× the dose of the standard vial kit.
What the peptide is.
Astranordic pen presentation of the dermal-peptide blend. Same formulation as the ChemAesthetic Glow vial, double dose, pen delivery.
GHK-Cu-dominant transcriptomic and SOD-mimetic effects.
Reconstitution, storage, and handling.
Lab-technical guidance for the researcher handling the material. Not therapeutic dosing, not administration guidance — those are not within the scope of this supply.
- Recommended solvent
- Pre-reconstituted
- Typical volume
- N/A
- Cold-chain shipped.
- Lyophilised
- Pre-filled pen — store 2–8 °C. Pen is shipped cold-chain; after first use it may be kept at 2–8 °C.
- Reconstituted
- Pens are pre-reconstituted. Once opened, use within the manufacturer-stated window (typically 4 weeks refrigerated).
- Shelf life · sealed
- See pen label — typically 18–24 months sealed under refrigeration.
- Shelf life · reconstituted
- Once pen is opened: ~4 weeks at 2–8 °C.
- ▸Protect from light — copper peptide.
This lot, documented.
Every shipment is accompanied by a signed four-page analytical report including the HPLC chromatogram, ESI-MS spectrum, purity calculation, and sample handling chain-of-custody.
The report you will receive is specific to the lot dispatched to you. The display below is a current representative example.
04:22:11▸lot 26-04-A received ┈ 5.00 g04:22:40▸weight check ┈ PASS ±0.4 mg04:23:12▸sample → janoshik ┈ 50 mg04:23:12▸tracking #jnk-921833405:18:03▸HPLC result ┈ 99.24 %05:18:04▸MS obs 4729.42 Da ┈ PASS05:18:05▸coa.pdf signed ┈ attached05:18:06▸lot approved ┈ LIVE
REPORT ID JA-26-04-012
SUBJECT Glow Blend 140 mg pen
DESIGNATION Astranordic Glow Pen
LOT 26-04-A
METHOD RP-HPLC, ESI-MS
COLUMN C18, 250 x 4.6 mm, 5 um
MOBILE PHASE A: 0.1% TFA in H2O
B: 0.1% TFA in ACN
GRADIENT 5 -> 65% B over 20 min
FLOW RATE 1.0 mL/min
DETECTION UV 214 nm
INJECTION 20 uL @ 0.5 mg/mL
---
PURITY (A%) 99.00
MASS EXP. —
MASS OBS. —
---
CONCLUSION Identity CONFIRMED · Purity PASS
SIGNED BY J. Novak, MSc · Janoshik Analytical SVK
DATE 2026-04-11Research references for Glow Blend 140 mg pen.
0 peer-reviewed publications. Links resolve to PubMed. DOIs are provided where available.
This peptide is supplied by Omega Grade for in vitro laboratory research use. It is not a drug, food, cosmetic, or dietary supplement. It is not approved by the FDA, EMA, MHRA, PMDA, or any other regulatory authority for any therapeutic indication.
No claim of therapeutic benefit is made or implied. The material is not intended for human or veterinary consumption, administration, or any form of self-experimentation. By purchasing, you acknowledge the researcher terms and accept full responsibility for local import compliance and all handling.
Often considered alongside.
Glow Blend 70 mg
Multi-peptide dermal blend — GHK-Cu + supporting peptides.
- Form
- Lyophilised kit
- Dose
- 70 mg / vial
- Purity
- ≥ 99.0% (component-level)
GHK-Cu 150 mg pen
Pre-filled copper-tripeptide pen — high-dose presentation.
- Form
- Pre-filled pen
- Dose
- 150 mg / pen
- Purity
- ≥ 99.6%